Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One-year, Randomized, Open Label, Parallel Group Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Either Full Dose or Reduced Dose Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients

NCT00238940 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00238940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00238940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One-year, Randomized, Open Label, Parallel Group Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Either Full Dose or Reduced Dose Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2003
Completion date
September 30, 2005
Enrollment
55 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation